22 employees
Theranexus is a clinical-stage pharmaceutical company that aims to develop technology to address severe medical needs in brain disorders.
2013
$4.5M
from 4 investors over 4 rounds
Theranexus raised $4.5M on November 17, 2014
Investors: Sofimacpartners, Rhône-Alpes Création, WILCO and Auriga Partners